Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fresenius Medical Care AG & Co KGaA (NYSE:FMS)

40.90
Delayed Data
As of Jul 31
 -0.14 / -0.34%
Today’s Change
32.40
Today|||52-Week Range
44.34
+10.12%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$24.9B

Company Description

Fresenius Medical Care AG & Co. KGaA is engaged in providing products and services for kidney dialysis patients. It operates through the North America and International segments. Both segments provide dialysis care services and distribute products and equipment for the treatment of end stage renal disease. It also offers chronic hemodialysis, home and acute therapies, therapeutic Aphaeresis, liver and therapy support, and renal pharmaceuticals. The company was founded on August 5, 1996 and is headquartered in Bad Homburg vor der Höhe, Germany.

Contact Information

Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
Bad Homburg vor der Höhe Hessen 61352
P:(496) 172-6090
Investor Relations:
4961726092525

Employees

Shareholders

Other institutional1.56%
Mutual fund holders0.39%
Individual stakeholders--

Top Executives

Rice PowellChief Executive Officer
Kent WanzekCEO-Global Manufacturing Operations
Michael BrosnanChief Financial Officer
Olaf SchermeierCEO-Global Research & Development
Roberto FustéCEO-Asia Pacific & Member-Management Board